References
- Algeri, E.J. and McBay, A.J. (1953). Am. J. Clin. Path. 23, 654–660.
- Bogan, J. and Smith, H. (1967). J. For. Sci. 7, 37–45.
- Coldwell, B.B., Trenholm, H.L., Thomas, B.H. and Charbonneau, S. (1971). J. Pharm. Pharmacol. 23, 947–949.
- Coldwell, B.B., Wiberg, G.S. and Trenholm, H.L. (1970). Can. J. Physiol. Pharmacol. 48, 254–264.
- Devengi, P. and Wilson, M. (1971a). Can. Med. Assoc. J. 104, 215–218.
- Devengi, P. and Wilson, M. (1971b). Can. Med. Assoc. J. 104, 219–221.
- Glatt, M.M. (1962). Bull. Narcotics, 14 19–38.
- Gupta, R.C. and Kofoed, J. (1966). Can. Med. Assoc. J. 94, 863–865.
- LeDain, G. (1970). Interim Report of the Commission of Enquiry into the Non-Medical Use of Drugs. Queen's Printer, Ottawa. p. 285.
- Leslie, C.A., Gottesfeld, Z. and Elliott, K.A.C. (1971). Can. J. Physiol. Pharmacol. 49, 833–840.
- Rubin, E., Bacchin, P., Gang, H. and Lieber, C.S. (1970). Lab. Invest. 22, 569–580.
- Rubin, E., Gang, H., Misra, P.S. and Lieber, C.S. (1970). Amer J. Med. 49, 801–806.
- Rubin, E. and Lieber, C.S. (1968). Science, 162, 690–691.
- Schuppel, R. (1969). Naunyn-Schmeidebergs. Arch exp. Path. Pharmak. 265, 156–169.
- Seidel, G. (1967). Naunyn-Schmeidebergs Arch. exp. Path. Pharmak. 257, 221–229.
- Titus, E. and Weiss, H. (1955). J. Biol. Chem. 214, 807–820.
- Wiberg, G.S., Coldwell, B.B. and Trenholm, H.L. (1969). J. Pharm. Pharmacol. 21, 232–236.